Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CTEC: Cholestech any other investors? -- Ignore unavailable to you. Want to Upgrade?

To: Duane L. Olson who wrote (476)	4/1/1998 9:32:00 PM
From: Phil Rogers	Read Replies (1) \| Respond to of 710

<< would it not identify a LOT of folks who would need fairly continuous tesing and monitoring of cholesterol levels >> Duane: Currently, there is a very large population base that requires cholesterol monitoring. I mean a very, very , VERY LARGE population base. Amongst my colleagues we joke that cholesterol lowering agents should be added to the public water supply, like fluoride, especially since some good, large studies released during the November 1997 AHA meetings (namely LIPID and TexCAPS/AFCAPS). These studied confirmed prior knowledge and added new information, broadening the number of patients that might require monitoring and treatment. *** Of course I AM joking about the water supply. I don't want to start a panic. I, however, do not think that the implications of the high speed CT study would make a significant dent in the number of patients that would need screening that do not already need screening. The cost of cholesterol screening is negligible compared to the cost of high speed CT. The patients that would get referred for this procedure are not the broad population base (or a fraction of those recommended for cholesterol screening). Those that get referred for this procedure will be those patients that are sufficiently suspect of having coronary disease. We screen for cholesterol in a much healthier patient population. Also, if a patient went for this study, they would almost undoubtedly have had their cholesterol evaluated. I hope this answers your question. If I was unclear let me know. All of this being said, I like and own CTEC. There is plenty of potential business out there for them without this issue being invoked. Phil